Synthimed Labs
Synthimed Labs is a biotechnology company focused on developing synthetic biology and biomaterials solutions for medical and life science applications. It appears to work on research-driven products and services for healthcare and scientific customers, though detailed public information about its commercial offerings is limited.
- Revenue
- $1.5M
- Employees
- 15
- Founded
- 2019
- Headquarters
- San Diego, United States of America
What 17 Arbolus experts think of Synthimed Labs
Synthimed receives strong NPS scores (8-10) from the majority of experts, especially those with over a year of engagement and higher annual spend. Renewal intent is high, with nearly all respondents (except one 'Not Sure') indicating plans to continue, especially among Influencers and business leads. Stickiness is reinforced by multi-year contracts and reports of flexibility in engagement. Key feedback highlights include praise for cost-value balance, reliable chemistry execution, and fast turnaround, balanced by constructive criticism regarding limitations in integrated biology-discovery services and scalability for major portfolio expansions.Overall Customer Sentiment: Positive
Who reviewed Synthimed Labs
- C-Suite 71% (12)
- Director 24% (4)
- Manager 6% (1)
Employer names and spend open in the full report, along with the other 14 customers.
Everything 17 customers told us about Synthimed Labs.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
52 Net Promoter Score, from 17 scored reviews- Promoters 10
- Passives 6
- Detractors 1
Cumulative NPS by month
+0 over 5 months- Oct 9
- Feb 8
- Mar 8
- Jul 9
- Aug 9
Net Promoter Score across 2 reviews, accumulated up to each month. Category median 42 across 2 companies.
Praised
- Reliable Execution for Mid-Complexity Chemistry
- Flexibility and Responsiveness
- Strong Cost to Value Balance
- Expansion into AI-Assisted and Integrated Platform Services
Criticised
- Compliance and Data Security Concerns
- Reliability and Execution Gaps
- Pricing and Cost Competition
- Consistency Post-Acquisition Needs to Be Proven
What customers say
Renewal intent
Plan to renew 75%Plan to renew, by seniority
- 73% 11 answers
- 75% 4 answers
- 100% 1 answer
- 8.7/10 Average score from customers who will renew
- 8.5/10 Average score from undecided customers
Top alternatives
Most weighed by Synthimed Labs customersReport
For people who use Synthimed Labs
Do you use Synthimed Labs at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 17 customers of Synthimed Labs have already contributed
Takes a few minutes. Your identity stays anonymous.